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i) blood cultures: Gram-positive 51%, Gram-negative 44%, mixed
5%, fungi 0%; ii) Septifast: Gram-positive 27%, Gram-negative 59%,
mixed 8%, fungi 6%. Using blood cultures as reference, sensitiv-
ity of Septifast PCR was 38% (13% in Gram-positive, 57% in Gram-
negative), specificity 64%, PPV 26%, NPV 76%. 39% of pathogens
not detected by Septifast were not included in the test spec-
trum. Performance of blood cultures and Septifast PCR in differ-
ent settings are shown in the table. Microbiological documenta-
tion was obtained by Septifast PCR in 29/98 (30%) blood culture-
negative episodes: 19/51 (37%) CDI and 10/44 (23%) FUO. 19/23
(83%) pathogens identified by Septifast in CDI were consistent with
the site of infection. Fungi were detected in 5 blood cultures-
negative episodes of probable or possible invasive mycoses (Can-
dida 4, Aspergillus 1).
Positive Positive P value
blood cultures Septifast PCR
No antibacterial therapy (n=93) 27 (29%)* 19 (20%)** 0.23
Antibacterial therapy (n=144) 13 (9%)* 42 (29%)** <0.001
Onset of fever, D1 (n=49) 9 (18%) 17 (35%) 0.11
Persistent fever, D3 (n=95) 4 (4%) 25 (26%) <0.001
*P<0.001, **P=0.17.
Conclusions: Septifast PCR is a promising additional tool for the
microbiological documentation of blood culture-negative febrile
neutropenic episodes. Septifast may be particularly useful in pa-
tients receiving antibiotics at time of blood sampling or with per-
sistent fever.
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Background: Invasive Fungal Infections (IFI) are life-threatening
complications in neutropenic patients with Acute leukemia (AL).
The diagnosis of IFI is challenging because of the lack of specificity
of clinical signs and the low sensitivity of cultures. This results in a
large empirical use of antifungal agents. Septifast (Roche), a new
PCR-based blood assay for detection of bacterial and fungal DNA
in patients with sepsis, may contribute to the early diagnosis of IFI
during neutropenia.
Objective: To assess the efficiency of Septifast PCR for the diag-
nosis of IFI in neutropenic patients with AL.
Method: Pilot observational prospective study. Blood samples for
Septifast PCR were drawn in adult febrile neutropenic patients
with AL at onset of fever and twice weekly during persistent fever.
IFI were classified as proven, probable or possible according to the
EORTC-MSG criteria. The efficiency of Septifast PCR for the diagno-
sis of IFI was compared to that of clinical assessment (EORTC-MSG
criteria).
Results: One hundred and three samples were analyzed during 65
febrile episodes in 34 patients. 7 (11%) episodes were classified
as probable or possible IFI (3 probable candidiasis, 2 probable as-
pergillosis, 2 possible IFI). No fungemia was detected by blood cul-
tures. Septifast PCR detected fungi in 6 febrile episodes as shown
in the table. Using EORTC-MSG criteria as gold standard for the di-
agnosis of IFI, sensitivity of Septifast PCR was 71%, specificity 98%,
PPV 83%, NPV 97% and efficiency 95%. Septfiast PCR positivity pre-
ceded the diagnosis of IFI by EORTC-MSG criteria in 3/4 cases and
start of empirical antifungal therapy in 1/4 cases.
Detection by Septifast PCR EORTC-MSG criteria
Probable IFI Possible IFI No IFI
Candida spp. (n=5) 3 1 1
C. albicans (n=3) 2 1 –
C. tropicalis (n=2) 1 – 1
Aspergillus spp. (n=1) – 1 –
A. fumigatus (n=1) – 1 –
No pathogen 2* – –
*Probable pulmonary aspergillosis (positive CT-Scan + galactomannan in
BAL).
Conclusions: This pilot study suggests that Septifast PCR blood as-
say may be an efficient tool for the early diagnosis of invasive
mycoses in neutropenic patients with acute leukemia. Excellent
test' s specificity and negative predictive value might contribute to
targeted use of antifungal therapy.
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Objectives: The pattern of infections in neutropenic patients is
changing over time along with our clinical practices and antibi-
otic usage. A prospective observational multicenter study was con-
ducted to record the type and frequency of infections in neu-
tropenic patients with haematological malignancies.
Patients and Methods: The study was conducted between May
2007 and September 2007 in seven tertiary care hospitals located
in different geographic compartments of Greece. Eligible were all
the patients with haematological malignancy and chemotherapy-
induced neutropenia (neutrophil count <500/mm3). Pertinent in-
formation regarding patients' demographic characteristics, under-
lying disease, therapeutic modalities, duration of neutropenia, and
clinical course was abstracted in a pre-designed form.
Results: Three hundred and two patients were enrolled in the
study; 156 males and 146 females with median age 50 years (0.2
to 88 years). Sixty-three patients had ALL, 117 AML, 2 CLL, 2 CML,
1 MDS, 27 MM, 62 NHL and 28 HD. Twenty-five patients had under-
gone allogeneic bone marrow transplantation and 45 autologous.
Ninety-three patients (31%) had long-lasting central vein catheter
(CVC). The median duration of neutropenia was 9 days (1 to 57
days) with a median nadir of 80/mm3 (0 to 500). Two hundred and
thirty patients (74%) developed fever during neutropenia. Pres-
ence of CVC, duration, and depth of neutropenia were indepen-
dent risk factors for a febrile episode. In 137 patients (59.6%)
the fever was attributed to infection, whereas in the remaining
93 febrile patients (40.4%) no causative agent was identified. The
isolated organisms and the source of isolation are shown in Ta-
ble 1.
One hundred and twenty-seven courses of anti-fungal treatment
were given, of which 71 on empiric basis. Twenty-one of 230 (9.1%)
febrile patients died because of infection.
